Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2007 1
2014 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
Anti-inflammatory and anti-mutagenic effect of the YHK phytocompound in hepatocytes: in view of an age-management liver-protecting approach.
Catanzaro R, Celep G, Illuzzi N, Milazzo M, Rastmanesh R, Yaduvanshi SK, He F, Trushin M, Sapienza C, Srivastava N, Marotta F. Catanzaro R, et al. Rejuvenation Res. 2014 Apr;17(2):168-71. doi: 10.1089/rej.2013.1492. Epub 2014 Apr 8. Rejuvenation Res. 2014. PMID: 24050307 Free article.
Our study showed that YHK significantly reduced cellular growth in the HuH7 cell line (p<0.05). Moreover, this phytocompound partly reduced gene expression of NF-kappaB p65 (by 35%, p<0.05). These data suggest that YHK has a potential role as a modulator of RA …
Our study showed that YHK significantly reduced cellular growth in the HuH7 cell line (p<0.05). Moreover, this phytocompound partl …
Phytotherapeutic compound YHK exerts an inhibitory effect on early stage of experimentally-induced neoplastic liver lesions.
Marotta F, Harada M, Goh K, Lorenzetti A, Gelosa F, Minelli E. Marotta F, et al. Ann Hepatol. 2006 Oct-Dec;5(4):268-72. Ann Hepatol. 2006. PMID: 17151579 Free article.
The aim of this study was to investigate the effects of the herbal compound YHK on hepatocarcinogenesis induced by diethylntrosamine (DEN) in Sprague Dawley rats. ...Moreover, co-administration of YHK significantly reduced the incidence, number, size and volume of h …
The aim of this study was to investigate the effects of the herbal compound YHK on hepatocarcinogenesis induced by diethylntrosamine …
Yo Jyo Hen Shi Ko (YHK) improves transaminases in nonalcoholic steatohepatitis (NASH): a randomized pilot study.
Chande N, Laidlaw M, Adams P, Marotta P. Chande N, et al. Dig Dis Sci. 2006 Jul;51(7):1183-9. doi: 10.1007/s10620-006-8030-y. Dig Dis Sci. 2006. PMID: 16944007 Clinical Trial.
Eight patients were randomized to YHK or placebo for 8 weeks. The ALT and AST were measured at baseline and weeks 4, 8, and 12. ...YHK is well tolerated. Further studies are justified to assess the impact of YHK in the natural history of NASH....
Eight patients were randomized to YHK or placebo for 8 weeks. The ALT and AST were measured at baseline and weeks 4, 8, and 12. ... …
In vitro study on the mechanisms of action of a novel phytotherapeutic compound against human hepatoma cells.
Marotta F, Harada M, Goh KL, Lorenzetti A, Marandola P, Minelli E. Marotta F, et al. Ann Hepatol. 2007 Apr-Jun;6(2):111-6. Ann Hepatol. 2007. PMID: 17519835 Free article.

As compared to control, YHK-treated cultures showed a significant time-course decrease of the proliferation rate of HepG2 cell growth (p < 0.01). ...These data suggest that YHK seem to modulate the extrinsic and intrinsic regulators of apoptosis and sensitize tum

As compared to control, YHK-treated cultures showed a significant time-course decrease of the proliferation rate of HepG2 cell growth …
Liver exposure to xenobiotics: the aging factor and potentials for functional foods.
Marotta F, Lecroix P, Harada M, Masulair K, Safran P, Lorenzetti A, Ono-Nita SK, Marandola P. Marotta F, et al. Rejuvenation Res. 2006 Summer;9(2):338-41. doi: 10.1089/rej.2006.9.338. Rejuvenation Res. 2006. PMID: 16706665
Hepatocytes isolated from 20- and 4-month Wistar rats and cultured with or without alpha-linolenic acid (LNA) were then added with nutraceutical YHK or sylibin before the test with iron or copper. Overall, YHK proved to be more effective than sylibin in Fe/Cu-induce …
Hepatocytes isolated from 20- and 4-month Wistar rats and cultured with or without alpha-linolenic acid (LNA) were then added with nutraceut …